A phase 2b, randomized, double-blind, placebo-controlled, clinical trial of atacicept for treatment of IgA nephropathy-Reference-Cited by-同舟云学术

A phase 2b, randomized, double-blind, placebo-controlled, clinical trial of atacicept for treatment of IgA nephropathy

Published:2024-06 Issue:6 Volume:105 Page:1306-1315
ISSN:0085-2538
Container-title:Kidney International
language:en
Short-container-title:Kidney International

Author:

Lafayette Richard,Barbour Sean,Israni Rubeen,Wei Xuelian,Eren Necmi,Floege Jürgen,Jha Vivekanand^ORCID,Kim Sung Gyun^ORCID,Maes Bart,Phoon Richard K.S.,Singh Harmeet,Tesař Vladimír,Lin Celia J.F.,Barratt Jonathan^ORCID

Publisher

Elsevier BV

Reference25 articles.

1. IgA nephropathy;Lai;Nat Rev Dis Primers,2016

2. Epidemiology of IgA nephropathy: a global perspective;Schena;Semin Nephrol,2018

3. The incidence of primary glomerulonephritis worldwide: a systematic review of the literature;McGrogan;Nephrol Dial Transplant,2011

4. Life expectancy for patients from the southeastern United States with IgA nephropathy;Hastings;Kidney Int Rep,2018

5. Mortality in IgA nephropathy: a nationwide population-based cohort study;Jarrick;J Am Soc Nephrol,2019

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The pathogenesis of IgA nephropathy and implications for treatment;Nature Reviews Nephrology;2024-09-04

2. Targeting APRIL in the treatment of glomerular diseases;Kidney International;2024-09

3. Contemporary review of IgA nephropathy;Frontiers in Immunology;2024-08-12

4. The mucosal microbiome and IgA nephropathy: a new target for treatment?;Kidney International;2024-08

5. Navigating Adult-Onset IgA Vasculitis-Associated Nephritis;Life;2024-07-25